---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-031991"
form_type: "8-K"
ticker: "PLSH"
cik: "0001552189"
company_name: "PANACEA LIFE SCIENCES HOLDINGS, INC."
filed_at: "2021-12-20T23:59:59+00:00"
generated_at: "2026-06-27T23:41:29.824996+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Panacea Life Sciences restates Q3 2021 financials; board cites errors in revenue, COGS, leases, warrants

## Summary
- Board concluded Q3 2021 unaudited financials filed Nov 22 should no longer be relied upon due to errors in revenue, cost of goods sold, lease liability, options and warrants.
- Restated financials filed in amended 10-Q/A on Dec 17, 2021, affecting balance sheet, income statement, equity, and cash flow statements.
- Original 10-Q was not reviewed by independent accountant RBSM prior to filing; amended report was reviewed and may be relied upon.
- Board and CEO discussed the non-reliance determination with representatives of RBSM.

## SEC filing metadata
- accession: 0001493152-21-031991
- form_type: 8-K
- ticker: PLSH
- cik: 0001552189
- company_name: PANACEA LIFE SCIENCES HOLDINGS, INC.
- filed_at: 2021-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1552189/000149315221031991/0001493152-21-031991-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1552189/000149315221031991/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-031991
- JSON: https://secwatch.observer/filing/0001493152-21-031991.json
- Plain text: https://secwatch.observer/filing/0001493152-21-031991.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.